title: [Yohimbine in the treatment of erectile dysfunction].
abstract: Iochimbin hydrochloride was given to 153 men with erectile dysfunction. The results are available for 140 of them. The ability of iochimbin in a single dose of 5-10 mg to enhance arterial blood inflow to cavernous bodies of the penis was confirmed by dynamic angiopenoscintigraphy and Doppler ultrasonography. Iochimbin hydrochloride in a mean daily dose of 15-20 mg proved effective in erectile dysfunction--38 to 84% responders depending on the type of erectile dysfunction. Occasional side effects can be relieved by reducing the drug dose.
authors.forename: D Iu
authors.initials: DIu
authors.lastname: Pushkar'
authors.forename: A S
authors.initials: AS
authors.lastname: Segal
authors.forename: A G
authors.initials: AG
authors.lastname: Bagaev
authors.forename: P B
authors.initials: PB
authors.lastname: Nosovitskiĭ
mesh_terms: D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D007172:Erectile Dysfunction / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010413:Penis / Q000098:blood supply / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D012307:Risk Factors; D018608:Ultrasonography, Doppler; D015016:Yohimbine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000317:Adrenergic alpha-Antagonists; D015016:Yohimbine